Paine Schwartz Partners Makes Strategic Investment in Hendrix Genetics

Hendrix Genetics Merges Hypor with Danish Genetics to Form Global Swine Genetics Alliance

October 21, 2024

Agriculture

Hendrix Genetics has signed an agreement to merge its swine division, Hypor, with Danish Genetics and partners to create a combined swine-genetics entity in which Hendrix will hold a majority stake. The strategic combination is intended to expand product portfolios, strengthen R&D capabilities and broaden global distribution in the swine genetics market; the transaction is expected to close in early 2025.

Paine Schwartz Partners Makes Strategic Investment in HGS BioScience (Formerly Humic Growth Solutions)

September 20, 2022

Agriculture

Paine Schwartz Partners completed a strategic investment through its Food Chain Fund VI in HGS BioScience (formerly Humic Growth Solutions), a Jacksonville-based manufacturer of extracted humic and fulvic acid products. The investment (terms undisclosed) will support the company's growth, product innovation and operational scaling across its six North American manufacturing sites and global distribution footprint.

Paine Schwartz Partners Makes Growth Equity Investment in Advanced Agrilytics

September 17, 2019

Agriculture

Paine Schwartz Partners has made its first growth equity investment from Paine Schwartz Food Chain Fund V in Advanced Agrilytics, an agronomics services business that provides precision farming analytics and on‑the‑ground agronomic advice. Financial terms were not disclosed; the investment will support scaling the business, adding data scientists and agronomic professionals, and expanding customer and implementation teams.

Paine Schwartz Partners Invests in Kynetec

March 19, 2021

Data & Analytics

Paine Schwartz Partners has made a growth investment in Kynetec through Paine Schwartz Food Chain Fund V; financial terms were not disclosed. Kynetec, a provider of agricultural and animal health market research, data and insights based in Newbury, England (with operations in St. Louis, Missouri), will use the capital to accelerate growth, expand capabilities and pursue complementary bolt-on acquisitions.

Paine Schwartz Makes Growth Investment in Elemental Enzymes

June 5, 2023

Biotechnology

Paine Schwartz Partners (via Paine Schwartz Food Chain Fund VI) completed a strategic growth investment in Elemental Enzymes, a St. Louis-based developer of naturally occurring enzymes and biochemicals for commercial agriculture. Financial terms were not disclosed; the Elemental Enzymes management team will remain in place and will work with Paine Schwartz to expand R&D, launch new products, and enter new markets.

Ampersand Capital Partners Completes Growth Equity Investment in GenDx

May 8, 2019

Biotechnology

Ampersand Capital Partners completed a minority growth equity investment in Genome Diagnostics B.V. (GenDx), a Utrecht-based provider of molecular diagnostic kits and analysis software for transplantation and companion diagnostics. The partnership will support GenDx's organic growth and M&A strategy; Ampersand's David Parker and Operating Partner Mike Evans joined GenDx's board.